InvestorsHub Logo
Followers 11
Posts 287
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Sunday, 07/05/2015 10:33:29 PM

Sunday, July 05, 2015 10:33:29 PM

Post# of 54983
Interesting video found on FDA.gov regarding some of the research being done with XXII technology- Video: Tobacco Regulatory Science in Action--Eric Donny, Ph.D.

While the chart is still fighting long-term resistance from Oct '14, a close above .94 should trigger a technical buy signal (Bullish Harami Cross).

IMO XXII will be achieve at least $3-5M in quarterly sales by year's end or Q1 2016. Until that time, I do not foresee cash on-hand needed to fund day-to-day operations as being a significantly dilutive factor, if at all. I would expect the bulk of any offerings to be taken from the Shelf and used for ventures that only add value to the Company.

GO XXII!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News